Clinical trial
pErsonalised Nocebo Assessment of Beta-blockEr Symptoms in Heart Failure
NCT07029906 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- pErsonalised Nocebo Assessment of Beta-blockEr Symptoms in Heart Failure
- Lead sponsor
- Imperial College London
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 29, 2025
- Completion date
- December 31, 2027
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure, side-effect